Cue BiopharmaCUE

13F holders, Q1 2026 (March 31)
55holders +6
11new positions
6sold out
1famous investor
$0.23avg. 13F price*

At the end of Q1 2026, 55 institutions reported holding Cue Biopharma Inc. (CUE) in their 13F filings, up 6 from Q4 2025. 11 opened new positions and 6 sold out. The largest holders were Bleichroeder LP ($1.6M), GC Wealth Management RIA, LLC ($1.1M) and Vanguard Capital Management LLC ($565K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Cue Biopharma Inc.
CUSIP
22978P106
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080 Q1 2024: 77Q1 2024Q2 2024: 75Q2 2024Q3 2024: 50Q3 2024Q4 2024: 55Q4 2024Q1 2025: 49Q1 2025Q2 2025: 47Q2 2025Q3 2025: 52Q3 2025Q4 2025: 49Q4 2025Q1 2026: 55Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions11$79K
Exits6$246K

All 13F filers, Q4 2025 → Q1 2026: 665,980 shares bought and 1,061,430 shares sold, net −395,450 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 55 holders

Bleichroeder LP 0.27% No change 6,819,164 $1.6M
GC Wealth Management RIA, LLC 0.04% No change 4,631,644 $1.1M
Vanguard Capital Management LLC 0.00% — 2,457,452 $565K
Lion Point Capital, LP 3.03% No change 2,202,854 $506K
Geode Capital Management, LLC 0.00% Add +32.5% 1,064,690 $245K
Vanguard Fiduciary Trust Co. 0.00% — 543,585 $125K
Robertson Stephens Wealth Management, LLC 0.00% No change 478,500 $110K
BlackRock, Inc. 0.00% Reduce 0.0% 449,161 $103K
Texas Capital Bank Wealth Management Services Inc 0.01% Reduce -9.8% 397,421 $91K
Angeles Wealth Management, LLC 0.00% No change 310,000 $71K
Advisory Research Inc. 0.01% No change 257,225 $59K
Stifel Financial Corp. 0.00% No change 246,556 $57K
Chicago Partners Investment Group LLC 0.00% No change 85,937 $50K
Renaissance Technologies 0.00% Reduce -10.3% 213,828 $49K
Bank of America Corp. 0.00% Add +0.1% 207,708 $48K
State Street Corp. 0.00% No change 179,353 $41K
Diadema Partners LP 0.01% New 131,997 $30K
Northern Trust Corp. 0.00% Reduce -6.3% 94,607 $22K
UBS Group AG 0.00% Add +88.6% 88,350 $20K
Northwestern Mutual Wealth Management Co. 0.00% No change 79,500 $18K
Advisortrust Partners, LLC 0.00% New 50,000 $11K
Virtu Financial LLC 0.00% New 49,553 $11K
Sigma Planning Corp 0.00% Reduce -5.6% 38,750 $9K
Goldman Sachs Group Inc. 0.00% Add +137.6% 34,151 $8K
Persistent Asset Partners Ltd 0.00% New 33,369 $8K
Visionary Wealth Advisors 0.00% New 29,285 $7K
Miramontes Capital, LLC 0.00% No change 26,041 $6K
Susquehanna International Group, LLP 0.00% Reduce -85.4% 24,614 $6K
Gsa Capital Partners LLP 0.00% New 20,341 $5K
Cambridge Investment Research Advisors, Inc. 0.00% No change 20,000 $5K
NewEdge Advisors, LLC 0.00% No change 20,000 $5K
Prevail Innovative Wealth Advisors, LLC 0.00% No change 18,987 $4K
Morgan Stanley 0.00% Reduce -1.2% 18,374 $4K
LPL Financial LLC 0.00% Reduce -66.4% 15,590 $4K
XTX Topco Ltd 0.00% New 15,124 $3K
Vanguard Global Advisers, LLC 0.00% — 12,997 $3K
SeaCrest Wealth Management, LLC 0.00% No change 10,000 $2K
Beacon Pointe Advisors, LLC 0.00% New 10,000 $2K
Barclays PLC 0.00% No change 6,029 $1K
Gleason Group, Inc. 0.00% No change 6,000 $1K
NFSG Corp 0.00% No change 3,000 $690
Wells Fargo & Company 0.00% No change 2,563 $589
Dauntless Investment Group, LLC 0.00% New 2,416 $555
Golden State Wealth Management, LLC 0.00% No change 2,000 $460
Physician Wealth Advisors, Inc. 0.00% No change 1,006 $232
Mather Group, Llc. 0.00% New 1,000 $230
Simplex Trading, LLC 0.00% Reduce -65.8% 875 $201
Jones Financial Companies LLLP 0.00% No change 400 $96
BNP Paribas Financial Markets 0.00% No change 415 $95
MAI Capital Management 0.00% No change 350 $81
Osaic Holdings, Inc. 0.00% Reduce -55.9% 300 $69
Armstrong Advisory Group, Inc. 0.00% No change 120 $28
IFP Advisors, Inc 0.00% No change 100 $23
JPMorgan Chase & Co. 0.00% No change 4 $1
Royal Bank of Canada 0.00% New 75 $0

"% of holder's portfolio" is CUE's weight in each manager's 13F, not the share of Cue Biopharma Inc. the manager owns.